Mianyang Central Hospital
Welcome,         Profile    Billing    Logout  
 184 Trials 
328 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Jie
NCT06241781: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

Not yet recruiting
2
64
RoW
GT101 injection, Gemcitabine injection
Grit Biotechnology
Adult
01/27
01/27
NCT06316960: Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

Recruiting
2
50
RoW
Avapritinib, AYVAKIT, Azacitidine Injection, Azacitidine, Decitabine Injection, Decitabine, Idarubicin Hydrochloride, Idarubicine, Cytarabine, CYTOSAR, Granulocyte Colony-Stimulating Factor, Recombinant Human Granulocyte Colony-Stimulating Factor Injection
Children's Hospital of Soochow University
AML, Childhood, Relapse/Recurrence, Refractory AML, Core Binding Factor Acute Myeloid Leukemia, C-KIT Mutation
03/26
03/27
GMCAII, NCT06221683: Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML

Recruiting
2
500
RoW
Homoharringtonine, Homoharringtonine injection, Cytarabine, Cytosar, Etoposide, Etoposide injection, Venetoclax, Venclexta, Mitoxantrone hydrochloride liposome, Mitoxantrone hydrochloride liposome injection, Recombinant Human Granulocyte Colony-Stimulating Factor, Recombinant Human Granulocyte Colony-Stimulating Factor Injection, Idarubicin Hydrochloride, Idarubicin hydrochloride injection, Sorafenib, Nexavar, Gilteritinib, Xospata Pill, Avapritinib, AYVAKIT
Children's Hospital of Soochow University
AML, Childhood, Acute Myeloid Leukemia
12/28
12/29
NCT05632861: HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

Recruiting
2
76
RoW
HuHuangLianzonggan capsule, Experimental group, HuHuangLianzonggan capsule placebo, Placebo group
Tasly Pharmaceutical Group Co., Ltd
NASH
12/24
12/24
NCT05959694: A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .

Recruiting
1/2
107
RoW
TQB3909 tablet
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
12/25
06/26
NCT06325267: Clinical Characteristics of Primary Liver Cancer

Recruiting
N/A
1000
RoW
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Primary Liver Cancer
08/24
08/24
NCT06325254: Clinical Characteristics of Metabolic Associated Fatty Liver Disease

Recruiting
N/A
3000
RoW
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Metabolic Associated Fatty Liver Disease, Clinical Features
08/24
08/24
SBRTLCES, NCT04274270: SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer

Not yet recruiting
N/A
60
RoW
Endostar, S1
Peking University Third Hospital, Mianyang Central Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Cancer Hospital, Peking University International Hospital, China-Japan Friendship Hospital, The fifth medical center of PLA general hospital, Second Hospital of Shanxi Medical University, Hiser Medical Center of Qingdao, Guangxi Ruikang Hospital, GEM flower hospital of Liaohe oil field, Tang-Du Hospital, Third Affiliated Hospital of Guizhou Medical University, Liuzhou Worker's Hospital, The Affiliated Hospital of Xuzhou Medical University, Dalian municipal central hospital affiliated of dalian medical university
Radiotherapy Side Effect
01/22
01/23
NCT04564573: Antidepressant Treatments and Cognitive Function of Bipolar Patients

Recruiting
N/A
124
RoW
Tianjin Anding Hospital
Bipolar Disorder, Cognition
07/22
10/22
NCT04562324: Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder

Recruiting
N/A
60
RoW
SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other antidepressants or antipsychotics or other sedative-hypnotics, Neurofeedback system
Tianjin Anding Hospital
Anxiety Disorder, Healthy
10/22
11/23
NCT04497493: Efficacy of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Major Depressive Disorder

Recruiting
N/A
75
RoW
Transcranial Direct Current Stimulation (tDCS)-active, active, Transcranial Direct Current Stimulation (tDCS)-sham, sham
Tianjin Anding Hospital
Major Depressive Disorders
10/22
03/23
NCT06000137: The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy

Completed
N/A
129
RoW
Dezocine, Sufentanil injection, sufentanil, Flurbiprofen, Granisetron Injection, granisetron
Eye & ENT Hospital of Fudan University
Patient-controlled Analgesia
01/23
01/23
NCT02972398: N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders

Recruiting
N/A
200
RoW
N-acetylcysteine, YiWeiShi, placebo comparator of N-acetylcysteine
Tianjin Anding Hospital
Major Depressive Disorders
07/23
09/23
NCT04971148: Correlation of Peak Tidal Inspiratory Flow Measured Before and After Extubation in Adult Patients With Hypoxemia

Terminated
N/A
5
Europe, US
HFNC flow set at patient peak tidal inspiratory flow, HFNC flow set at 1.33 times of patient peak tidal inspiratory flow, HFNC flow set at 1.67 times of patient peak tidal inspiratory flow, HFNC flow set at 2 times of patient peak tidal inspiratory flow
Rush University Medical Center, Hospital Vall d'Hebron
Hypoxemic Respiratory Failure
08/23
08/23
NCT04341467: Amisulpride Treatment for BPSD in AD Patients

Recruiting
N/A
76
RoW
Amisulpride, Solian, Olanzapine, Oulanning
Tianjin Anding Hospital
BPSD, Amisulpride, Olanzapine, Dementia of the Alzheimer Type
12/23
05/24
PROTECT-2, NCT06134908: PRevention of OsTEoporotiC FracTure 2 Pilot Study

Recruiting
N/A
50
RoW
Multifaceted Intervention
Third Affiliated Hospital, Sun Yat-Sen University, Sir Run Run Shaw Hospital, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Longgang Orthopedics Hospital of Shenzhen, The First People's Hospital of Hefei, Dongguan Eighth People's Hospital, The Third People's Hospital of Longgang District Shenzhen
Fragility Fracture
06/25
06/27
NCT06269419: Study of Natural Course Progression of Diabetic Retinopathy

Recruiting
N/A
200
RoW
Jie Li
Biomarkers of Diabetic Retinopathy
01/29
01/29
NCT06300918: A Clinical Trial to Evaluate the Time Point of Anti-VEGF Pretreatment of PDR Based on Intraoperative FFA

Recruiting
N/A
60
RoW
Time
Jie Li
The Condition of Fundus Neovascularization
08/25
08/25
NCT05932095: TCM Daoyin in the Treatment of Patients With Anxiety State

Recruiting
N/A
20
RoW
TCM Daoyin, Qigong, Health education
Shanghai University of Traditional Chinese Medicine, Shanghai Mental Health Center
Anxiety State
03/24
08/24
NCT06228703: The Effects of Different Flow Settings on Lung Impedance

Recruiting
N/A
26
US
High-flow nasal cannula device with flow setting at 40 L/min or higher, HFNC flow at 40 L/min or higher
Rush University Medical Center
Healthy
09/24
12/24
NCT05589337: Baduanjin Training for Depression and Anxiety Patients

Recruiting
N/A
120
RoW
Baduanjin, Eight-section Brocade, Health education
Shanghai University of Traditional Chinese Medicine, Shanghai Mental Health Center
Depression Symptoms, Anxiety Symptoms
06/24
12/24
NCT05626309: Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer

Recruiting
N/A
310
RoW
Qizhu Yuling Prescription, Placebo, Simulation agent of Qizhu Yuling Prescription
Jie Li
Esophagus Cancer
08/24
11/24
NCT05766449: Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

Recruiting
N/A
1000
RoW
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Chronic Hepatitis b, Non-alcoholic Fatty Liver Disease
03/27
05/27
NCT05940480: TCM Daoyin Therapy in Individuals At-risk for COPD

Recruiting
N/A
60
RoW
TCM Daoyin, Qigong, Health education
Shanghai University of Traditional Chinese Medicine, Changzheng Community Health Service Center of Putuo District, Shanghai
Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
06/27
12/27
NCT05937178: Real-world Study Optimizing Nucleotide-analogues

Recruiting
N/A
20000
RoW
ETV/TAF/TDF/TMF/IFN, ETV/TAF/TDF/TMF
Huashan Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, Beijing YouAn Hospital, Peking University People's Hospital, Peking University First Hospital, Xiamen Hospital of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, LanZhou University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Hainan General Hospital, Hebei Medical University Third Hospital, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The Second Affiliated Hospital of Harbin Medical University, Tongji Hospital, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, the Second Hospital of Nangjing, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Hospital of Xuzhou Medical University, The First Affiliated Hospital of Nanchang University, Shengjing Hospital, Qingdao Sixth People's Hospital, Shandong Provincial Hospital Affiliated to Shandong First Medical University, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, West China Hospital, Tianjin Second People's Hospital, First Affiliated Hospital of Xinjiang Medical University, The First People's Hospital of Yunnan, Shulan (Hangzhou) Hospital, Zhejiang University, Southwest Hospital, China, The Second Affiliated Hospital of Chongqing Medical University, Sichuan Provincial People's Hospital
Hepatitis B, Chronic
01/29
01/29
EFLRWR, NCT05132218: Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer

Recruiting
N/A
180
RoW
Ensatinib, BD-EN-IV002
Beijing Cancer Hospital, Betta Pharmaceuticals Co., Ltd.
ALK Positive, NSCLC Stage IIIB, NSCLC Stage IV
10/22
10/24
Chen, Jia Ching
DCAP, NCT04868565: Target Weaning Oxygen to Determine Cafffeine Duration for AOP

Completed
4
310
RoW
Caffeine Citrate 20 MG/1 ML Intravenous Solution [CAFCIT]
Children's Hospital of Chongqing Medical University
Apnea of Prematurity, Caffeine, Weaning Oxygen, Medicine Regimen
10/23
10/23
NCT02323022: Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)

Completed
3
618
RoW
IAC regimen, IA regimen
The First Affiliated Hospital of Soochow University
Acute Myeloid Leukemia
01/20
01/22
NCT03719534: Haplo HCT vs Haplo-cord HCT for Patients With AML

Completed
3
134
RoW
haplo-HCT, haplo-cord HCT
The First Affiliated Hospital of Soochow University, Zhejiang University, The Second People's Hospital of Huai'an, Soochow Hopes Hematology Hospital, Hygeia Suzhou Yongding Hospital
Hematopoietic Stem Cell Transplantation, Haplo-identical Donor, Cord Blood Unit, Acute Myeloid Leukemia
12/22
03/23
PROSPECT, NCT02518594: A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix

Recruiting
3
630
US
Vaginal progesterone, Prometrium, Placebo, Arabin Pessary
The George Washington University Biostatistics Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Short Cervical Length
03/25
04/25
SZ4601, NCT03919240: CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Recruiting
1/2
50
RoW
CAR T-cell therapy
The First Affiliated Hospital of Soochow University, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Acute Lymphoblastic Leukemia With Failed Remission
12/20
12/23
NCT04686929: Abatacept s.c. for aGVHD Prevention in Haplo-HCT

Recruiting
1/2
29
RoW
Abatacept s.c.
The First Affiliated Hospital of Soochow University
Abatacept, Acute-graft-versus-host Disease, Haplo-identical HCT, Prevention
06/23
12/23
NCT03487185: Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

Recruiting
N/A
1500
US
Continuous Positive Airway Pressure, CPAP, Sleep Advice Control
The George Washington University Biostatistics Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI)
Obstructive Sleep Apnea of Adult, Preeclampsia, Obstetrical Complications
12/26
12/26
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma

Recruiting
N/A
300
RoW
Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Hepatocellular Carcinoma
03/26
03/26
DU, XIAOBO
FOCUS-C, NCT05334277: Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

Recruiting
2
280
RoW
Furmonertinib, AST2818, Furmonertinib/Pemetrexed/Carboplatin, Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab
Sun Yat-sen University, Allist Pharmaceuticals, Inc., GeneCast Biotechnology Co., Ltd.
Non-small Cell Lung Cancer
02/25
02/28
NCT05405439: To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer

Terminated
1/2
39
RoW
TQB3823 tablets, Abiraterone acetate tablets, prednisone acetate tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Metastatic Castration-resistant Prostate Cancer
07/23
07/23
NCT05959694: A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .

Recruiting
1/2
107
RoW
TQB3909 tablet
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
12/25
06/26
NCT06010901: A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.

Recruiting
1
75
RoW
TQB2618 injection, Penpulimab injection, Anlotinib hydrochloride capsules
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Colorectal Cancer
03/25
07/25
SBRTLCES, NCT04274270: SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer

Not yet recruiting
N/A
60
RoW
Endostar, S1
Peking University Third Hospital, Mianyang Central Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Cancer Hospital, Peking University International Hospital, China-Japan Friendship Hospital, The fifth medical center of PLA general hospital, Second Hospital of Shanxi Medical University, Hiser Medical Center of Qingdao, Guangxi Ruikang Hospital, GEM flower hospital of Liaohe oil field, Tang-Du Hospital, Third Affiliated Hospital of Guizhou Medical University, Liuzhou Worker's Hospital, The Affiliated Hospital of Xuzhou Medical University, Dalian municipal central hospital affiliated of dalian medical university
Radiotherapy Side Effect
01/22
01/23
Li, Hui
NCT05469685: Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication

Completed
4
914
RoW
Vonoprazan, Amoxicillin
Nanjing First Hospital, Nanjing Medical University
Helicobacter Pylori Infection
08/23
09/23
NCT05649540: Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori

Recruiting
4
900
RoW
Vonoprazan, Amoxicillin
Nanjing First Hospital, Nanjing Medical University
Helicobacter Pylori Infection
12/24
12/24
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting
4
8250
RoW
Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy
Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases
04/25
04/25
HER2CLIMB-02, NCT03975647: A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

Calendar Jan 2024 - Dec 2024: From HER2CLIMB-02 trial for breast cancer
Hourglass Jan 2022 - Dec 2022 : Completion of enrollment of HER2CLIMB-02 trial in combination with Kadcyla for breast cancer
Recruiting
3
565
Europe, Canada, Japan, US, RoW
tucatinib, ONT-380, placebo, T-DM1, Kadcyla
Seagen Inc.
HER2-positive Breast Cancer
06/23
10/27
TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

Active, not recruiting
3
531
RoW
JS001, Nab-Paclitaxel, Placebo
Shanghai Junshi Bioscience Co., Ltd.
Triple-Negative Breast Cancer
12/23
12/24
NCT05433480: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer

Active, not recruiting
3
274
RoW
BPI-16350, placebo, Fulvestrant
Betta Pharmaceuticals Co., Ltd.
Breast Cancer
12/23
07/25
SHINY, NCT06157502: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke

Recruiting
3
1380
RoW
Shuxuening Injection, Placebo
Beijing Tiantan Hospital
Ischemic Stroke, Acute
06/25
12/26
NCT05555706: Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Recruiting
2/3
450
RoW
B013+Nab-Paclitaxel
Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd
Triple Negative Breast Cancer (TNBC)
12/24
12/26
NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Recruiting
2
460
RoW
TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Obstructive Pulmonary Disease (COPD)
01/24
05/24
NCT05987371: A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.

Recruiting
2
72
RoW
TQC3721 suspension for inhalation, TQC3721 matching placebo for inhalation, Salbutamol sulfate inhalation aerosol
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Obstructive Pulmonary Disease
01/24
03/24
NCT06254521: The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

Recruiting
2
60
RoW
Tislelizumab combined with chemotherapy
First Affiliated Hospital of Guangxi Medical University
Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III
12/24
12/27
SAV, NCT05736965: A Study of Selinexor in Combination With Azacitidine and Venetoclax ( Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia

Recruiting
2
58
RoW
Selinexor, xpo1 inhibitor, Azacitidine, Venetoclax, ABT199
Shanghai Tong Ren Hospital
AML, Adult
03/25
04/27
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
539
RoW
BuMA Supreme, BuMAâ„¢
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
03/18
12/25
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
1000
RoW
BuMA Supreme
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
05/19
12/25
OPTIMAL, NCT03084991: OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarction

Recruiting
N/A
4500
RoW
Harbin Medical University, Abbott
Acute Myocardial Infarction
07/21
12/22
SIBLINT ISR, NCT04240444: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Completed
N/A
260
RoW
drug-coated balloon Catheter
B. Braun Medical International Trading Company Ltd., CCRF Inc., Beijing, China
Coronary Artery Disease, In Stent Restenosis
07/22
08/22
NCT04883177: Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Completed
N/A
1000
RoW
Hepatopancreatobiliary Surgery Institute of Gansu Province, LanZhou University, Huashan Hospital, The Sixth People's Hospital of Shenyang City, Xingtai City People's Hospital, Jinchang Central Hospital, Baoding People's Hospital, The Third People's Hospital of Zhenjiang City, Shanxi Bethune Hospital, Wuhan Jinyintan Hospital, Jincheng People's Hospital, The Third People's Hospital of Tibet Autonomous Region, People's Hospital of Ningxia Hui Autonomous Region, Fuling Central Hospital of Chongqing City, Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region, The Central Hospital of Lishui City, The Third People's Hospital of Linfen City, Yibin First People's Hospital, Jingzhou Central Hospital, Wuxi Fifth People's Hospital, Qingyang People's Hospital, The First Affiliated Hospital of Anhui Medical University, Beilun Hospital of Traditional Chinese Medicine, Henan Provincial People's Hospital, Qingdao Sixth People's Hospital, The First Affiliated Hospital of Xiamen University, Shandong Provincial Hospital, Beijing YouAn Hospital, The First People's Hospital of Taicang, The Third People's Hospital of Taiyuan, Tianjin Second People's Hospital, Tianjin Third Central Hospital, Qishan Hospital of Yantai City, Affiliated Hospital of Yunnan University, The First People's Hospital of Yunnan, The Fourth Affiliated Hospital of Zhejiang University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Chongqing Medical University
COVID-19, Liver Disease, Vaccine Reaction
01/22
05/22
BEYOND-II, NCT03820622: The Safety and Efficacy of DIOR Balloon in Coronary Bifurcation Lesions

Not yet recruiting
N/A
220
RoW
Paclitaxel-Eluting Coronary Balloon Dilation Catheter (DIOR), Paclitaxel-Eluting Balloon (Bingo)
CCRF Inc., Beijing, China
Percutaneous Coronary Intervention
05/22
10/22
NCT04953117: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease

Recruiting
N/A
286
RoW
DCB of Lepu Medical(dimeter≥2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary small vessels, Restore DEB, RESTORE Paclitaxel releasing coronary balloon catheter, DCB of Lepu Medical(dimeter<2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary very small vessels
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease
06/22
04/23
NCT04714918: Chinese CKD-MBD Prevalence Survey (CRISS-MBD)

Recruiting
N/A
10254
RoW
Limeng Chen
Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder
12/24
12/24
FAIR-Pilot, NCT05732077: Fractional Flow Reserve to Determine Atherosclerosis Renovascular Hypertension Stenting

Recruiting
N/A
100
RoW
Dopamine, Fractional Flow Reserve, Renal, Renal artery stenting
Peking University First Hospital
Renal Artery Stenosis Atherosclerotic, Secondary Hypertension Renal Arterial
03/25
03/25
NCT06359795: Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Recruiting
N/A
50
RoW
18F-AlF-FAPI PET/CT, 99mTc-DTPA SPECT/CT
Peking University Third Hospital
Thyroid Eye Disease
12/27
12/27
NCT05044182: Decompression and Drainage Seton for Treatment of High Horseshoe Anal Fistula

Recruiting
N/A
92
RoW
Decompression and drainage seton, Cutting seton
China-Japan Friendship Hospital
Anal Fistula
12/23
01/24
REAL, NCT05970159: Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery

Recruiting
N/A
480
RoW
Shanghai Zhongshan Hospital, Takeda
Hepatocellular Carcinoma
06/24
03/25
NCT05755776: The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment

Recruiting
N/A
204
RoW
TMF, Heng Mu
The Second Affiliated Hospital of Chongqing Medical University, Jiangsu Hansoh Pharmaceutical Co., Ltd.
Chronic Hepatitis B
12/24
12/24
NCT05715710: Correlation Between Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small Vessel Disease

Recruiting
N/A
200
RoW
Zigong No.1 Peoples Hospital
Cerebral Small Vessel Disease
09/25
09/25
NCT05046925: PACU for Postoperative Care After Major Thoracic and Abdominal Surgery

Not yet recruiting
N/A
18000
RoW
postoperatively transferral to PACU, 24-hour PACU group, postoperatively transferral to ICU, 24-hour ICU group
First Affiliated Hospital of Zhejiang University
Anesthesia, Surgery--Complications
12/23
12/23
Li, Yi
EA-outcome, NCT03431142: Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial

Recruiting
4
7700
RoW
Clopidogrel, Clopidogrel+aspirin
Shenyang Northern Hospital
Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage
09/21
09/21
NCT05649540: Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori

Recruiting
4
900
RoW
Vonoprazan, Amoxicillin
Nanjing First Hospital, Nanjing Medical University
Helicobacter Pylori Infection
12/24
12/24
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

Active, not recruiting
4
2500
RoW
Sodium Oligomannate Capsules
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer Disease
04/24
04/25
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting
4
8250
RoW
Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy
Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases
04/25
04/25
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

Recruiting
4
1312
RoW
GV-971, Placebo
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer's Disease
06/29
12/29
NCT03236636: The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Recruiting
3
312
RoW
Icaritin, SNG-162, HUACHANSU PIAN, HUACHANSU PIAN(999)
Beijing Shenogen Biomedical Co., Ltd, Chinese Academy of Medical Sciences, NanJing PLA 81 Hospital, Peking University Cancer Hospital & Institute, Beijing Hospital, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Jinan Central Hospital, Linyi Tumour Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, Nanfang Hospital of Southern Medical University, First People's Hospital of Foshan, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Hebei Medical University Fourth Hospital, The First Hospital of Jilin University, Haikou People's Hospital, Fudan University, West China Hospital, Chongqing Traditional Chinese Medicine Hospital, Chifeng Municipal Hospital, The Affiliated Hospital of Hangzhou Normal University, The First Affiliated Hospital of Zhengzhou University, Guilin Medical University, China, The Third Xiangya Hospital of Central South University, Yunnan Provincial Hospital of Traditional Chinese Medicine, The Sixth People's Hospital of Shenyang
Advanced HBV-Related Hepatocellular Carcinoma (HCC)
12/22
12/22
NCT04693351 / 2020-004653-69: Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

Recruiting
3
700
Europe, Canada, US, RoW
Troriluzole, Placebo
Biohaven Pharmaceuticals, Inc.
Obsessive-Compulsive Disorder
04/25
04/25
NCT03342443: Effect of Memantine on Radiotherapy-related Cognitive Impairment

Recruiting
2/3
240
RoW
Memantine, Arm I, Placebo, Arm II
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Cognitive Impairment
10/24
12/24
NCT04711980: Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy

Not yet recruiting
1
402
RoW
Mudan granule, Mudan particle, Placebo, Placebos
Fengmei Lian, Peking Union Medical College Hospital, Beijing Hospital, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Affiliated Hospital of Qingdao University, Chengdu University of Traditional Chinese Medicine, The Fourth People's Hospital of Chongqing, Zhengzhou Yihe Hospital Affiliated to Henan University, Zhu Xianyi Memorial Hospital of Tianjin Medical University, The Third Hospital of Xi'an, Huashan Hospital, Gansu Provincial People's Hospital, Shenzhen Hospital of Guangzhou University of Traditional Chinese Medicine, Affiliated Hospital of Changchun University of Chinese Medicine
Diabetic Peripheral Neuropathy Type 2
02/22
09/22
NCT06339021: OCT or Angiography Guided De-escalation of DAPT

Not yet recruiting
1
80
RoW
OCT-guided PCI, Conventional angiography-based PCI, DAPT de-escalation, default DAPT regimen
Shenyang Northern Hospital
Optical Coherence Tomography, Dual Antiplatelet Therapy, Antiplatelet De-escalation, Neointimal Coverage, ST Elevation Myocardial Infarction
12/26
12/26
NCT06199323: Acupuncture Therapy on Dysphagia in Parkinson's Disease

Completed
N/A
112
RoW
Routine rehabilitation training, Swallowing rehabilitation training, Acupuncture therapy
Zeng Changhao
Parkinson Disease
05/21
05/21
NCT06199375: Effect of Modified Mirror Therapy in Patients With Upper Limb Hemiparesis After Stroke

Terminated
N/A
116
RoW
Routine treatment, Comprehensive routine treatment, Rehabilitation training, Modified mirror therapy
Zeng Changhao
Stroke
07/23
08/23
NCT04209166: A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features

Recruiting
N/A
780
RoW
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors), SSRIs/SNRIs+Mood Stabilizer, SSRIs/SNRIs+Quetiapine, Usual Treatment
Shanghai Mental Health Center, Air Force Military Medical University, China, Guangzhou Psychiatric Hospital, Dalian Seventh People's Hospital, Wuhan Union Hospital, China, Shanghai Jiao Tong University School of Medicine
Major Depressive Disorder
10/22
10/22
BST-AMI, NCT05201274: Baduanjin Sequential Therapy and Cardiac Function of AMI With Reduced EF After PCI

Recruiting
N/A
140
RoW
Baduanjin sequential therapy, Aerobic exercise
Shenyang Northern Hospital
AMI
02/23
02/23
NCT05773534: Calf Muscle Perfusion in Patients With Intermittent Claudication by 3D-reconstruction of MSOT (MSOT_IC_3D)

Recruiting
N/A
30
Europe
MSOT, multispectral optoacoustic tomograph
Ulrich Rother, Ph.D. Student Niklas Holzwarth, Inteligent Medical Systems, German Cancer Research Center
Diagnostic Imaging, Peripheral Arterial Disease, Intermittent Claudication
03/23
05/23
NCT05773547: Investigation of the Learning Effect in the Measurement of Circulation in Calf Muscle Using MSOT

Recruiting
N/A
20
Europe
MSOT measurements
University Hospital Erlangen
Multispectral Optoacoustic Tomography, Learning Curve, Image Interpretation, Computer-Assisted, Structural Similarity Index Measure
04/23
05/23
NCT06208020: Cortical Function Changes During Swallowing in Patients With Dysphagia in Lateral Medullary Syndrome

Recruiting
N/A
20
RoW
Functional near-infrared spectroscopy (fNIRS) detection
The First Affiliated Hospital of Zhengzhou University
Deglutition Disorders, Lateral Medullary Syndrome
01/24
02/24
NCT06391346: Investigation of the Perfusion of Gluteal Muscle in Patients With Intermittent Gluteal Claudication by Non-invasive MSOT

Recruiting
N/A
20
Europe
MSOT
Ulrich Rother
Peripheral Vascular Diseases, Peripheral Arterial Disease, Intermittent Claudication, Gluteal Claudication
03/24
04/24
Paradise, NCT05671315: A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

Recruiting
N/A
267
RoW
Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide analogue
Qing XIe
Chronic Hepatitis B, Intermediate to High Risk of HCC
08/23
04/26
NCT05773560: Virtual Reality in the Rehabilitation in Patients With Lower Limb Amputation.

Recruiting
N/A
20
Europe
virtual reality rehabilitation
University Hospital Erlangen
Amputation, Lower Limb, Rehabilitation, Activities of Daily Living, Virtual Reality, Lower Extremity
10/23
01/24
NCT06166082: Stanford Neuromodulation Therapy (SNT) for the Treatment-Resistant Depression

Recruiting
N/A
130
RoW
Active iTBS-DLPFC, Sham iTBS-DLPFC
Changping Laboratory, Xianyue Hospital, Xiamen, Hebei Mental Health Center, Baoding, HuiLongGuan Hospital, Beijing, Wuhan Mental Health Center, Wuhan, Zhumadian Second People's Hospital, Zhumadian
Treatment Resistant Depression
07/24
10/24
NCT03769922: Postoperative Progression of the Disease Following Extensive Versus Limited Mesenteric Excision for Crohn's Disease

Recruiting
N/A
116
RoW
Extensive mesenteric resection, Limited mesenteric excision
Jinling Hospital, China, University Hospital of Limerick, The Cleveland Clinic, Sixth Affiliated Hospital, Sun Yat-sen University, Sir Run Run Shaw Hospital
Postoperative Surgical Recurrence
01/24
01/25
NCT06211777: Effect of Intermittent Oro-esophageal Tube Feeding vs. Nasogastric Tube Feeding on Dysphagia Patients After Stroke

Withdrawn
N/A
80
RoW
Intermittent Oro-esophageal Tube Feeding, Nasogastric Tube Feeding, comprehensive rehabilitation therapy
Zeng Changhao, The First Affiliated Hospital of Zhengzhou University
Stroke
03/24
04/24
ST, NCT06201091: The Effect of Swallowing Training for Elderly People in the Community

Withdrawn
N/A
300
RoW
Systematic simple swallowing training, swallowing training
Zeng Changhao, The First Affiliated Hospital of Zhengzhou University
Dysphagia
02/24
02/24
NCT06206538: Efficacy of Stellate Ganglion Block in Patients With Parkinson's Disease

Withdrawn
N/A
80
RoW
Stellate ganglion block, Rehabilitation therapy, Rehabilitation Treatment
People's Hospital of Zhengzhou University, The First Affiliated Hospital of Zhengzhou University
Parkinson Disease
04/24
04/24
NCT06202807: Effect of Intermittent Oro-esophageal Tube vs. Nasogastric Tube on Feeding Amount in Stroke Patients

Withdrawn
N/A
80
RoW
Intermittent Oro-esophageal Tube Feeding, Nasogastric Tube Feeding, comprehensive rehabilitation therapy
Zeng Changhao, The First Affiliated Hospital of Zhengzhou University
Ischemic Stroke
04/24
04/24
OPT-GUIDNACE, NCT06216821: OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time

Not yet recruiting
N/A
3490
RoW
standard DAPT, OPT-CAD score guided DAPT de-escalation
Shenyang Northern Hospital
Acute Coronary Syndrome
12/25
12/25
COCAD, NCT06216847: Clinical Outcomes of Patients With Coronary Artery Disease

Not yet recruiting
N/A
10000
RoW
Shenyang Northern Hospital
Coronary Heart Disease (CHD)
10/26
10/30
IOE-TBI, NCT06261281: Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patient

Withdrawn
N/A
100
RoW
Rehabilitation therapy, Intermittent Oro-esophageal Tube Feeding, Nasogastric tube feeding
Zeng Changhao
Traumatic Brain Injury
07/24
07/24
NCT06286020: Effect of Virtual Reality Therapy on Dysphagia in Wallenberg Syndrome

Recruiting
N/A
80
RoW
Virtual Reality Therapy, Conventional dysphagia treatment
Zeng Changhao
Wallenberg Syndrome
07/24
07/24
NCT06265857: Effect of Multifunctional Nutrition Tube on Cerebral Small Vessel Disease Patients

Recruiting
N/A
88
RoW
Intermittent Oro-esophageal Tube Feeding, Nasogastric Tube Feeding, comprehensive rehabilitation therapy
Zeng Changhao, The First Affiliated Hospital of Zhengzhou University
Cerebral Small Vessel Diseases, Dysphagia
06/24
06/24
NSR-DEV, NCT04337697: Neonatal Seizure Registry - Developmental Functional EValuation

Active, not recruiting
N/A
280
US
University of California, San Francisco, University of Michigan, Stanford University, Duke University, Boston Children's Hospital, Children's National Research Institute, Massachusetts General Hospital, Children's Hospital of Philadelphia, Children's Hospital Medical Center, Cincinnati, National Institute of Neurological Disorders and Stroke (NINDS)
Neonatal Seizure, Hypoxic-Ischemic Encephalopathy, Stroke, Intracranial Hemorrhages, Epilepsy, Cerebral Palsy, Intellectual Disability
09/24
09/24
NCT06267950: Effect of Oral Feeding in Infants With Pierre Robin Syndrome

Recruiting
N/A
60
RoW
systematic therapy, intermittent oro-esophageal tube feeding, gastric tube feeding
Zeng Changhao
Pierre Robin Syndrome
10/24
10/24
 

Download Options